However, no significant disparity was observed in the overall improvement of endoscopic scores between UST and anti-TNF-α antibodies (<i>P</i> = .5938).<h4>Conclusions</h4>This study suggests that UST might be more effective than anti-TNF-α agents in treating small intestinal inflammation in Crohn's disease. The gene discussed is TNF; the disease is Crohn disease.